Global Blood Therapeutics Stock Quote

Global Blood Therapeutics Inc. Zacks Investment Research upgraded Global Blood Therapeutics from a sell rating.

Will Global Blood Therapeutics Gbt Report Negative Q1 Earnings What You Should Know Nasdaq

Shares of Global Blood Therapeutics NASDAQGBT decreased in after-market trading after the company reported Q4 results.

Global blood therapeutics stock quote. View todays stock price news and analysis for Global Blood Therapeutics Inc. Roth Capitals price objective indicates a potential upside of 22813 from the stocks previous close. Global Blood Therapeutics Inc.

Global Blood Therapeutics NASDAQGBT had its target price lowered by equities researchers at Roth Capital from 12800 to 12400 in a research report issued to clients and investors on Wednesday Benzinga reports. They currently have a hold rating on the stock. 3862 UNCH UNCH Volume.

Find real-time GBT - Global Blood Therapeutics Inc stock quotes company profile news and forecasts from CNN Business. Global Blood Therapeutics Inc. 124 350 DATA AS.

Real time Global Blood Therapeutics GBT stock price quote stock graph news analysis. Global Blood Therapeutics Inc. 30 40 50 60 70 80.

Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends. Find the latest Global Blood Therapeutics Inc. Global Blood Therapeutics NASDAQGBT had its target price reduced by Canaccord Genuity from 4500 to 4000 in a report issued on Wednesday Benzinga reports.

Get the latest Global Blood Therapeutics stock price and detailed information including GBT news historical charts and realtime prices. GBT stock quote history news and other vital information to help you with your stock trading and investing. May 13 2021 400 PM EDT.

Global Blood Therapeutics stock price target cut to 75 from 110 at SunTrust RH Jan. Created with Highcharts 901. The firm currently has a buy rating on the stock.

Company facts information and financial ratios from MarketWatch. 31 2020 at 804 am. Data is currently not available.

Several other equities research analysts also recently commented on the company. View which stocks have been most impacted by COVID-19. Global Blood Therapeutics stock was trading at 5485 on March 11th 2020 when Coronavirus COVID-19 reached pandemic status according to the World Health Organization WHO.

Global Blood Therapeutic GBTStock Quote and News. Since then GBT stock has decreased by 355 and is now trading at 3538. GBTNASDAQ GS Stock Quote - Global Blood Therapeutics Inc - Bloomberg Markets.

Global Blood Therapeutics Inc operates in the healthcare sector of. ET by Tomi Kilgore Global Blood Therapeutics downgraded to hold from buy at SunTrust RH. Quarterly Results Earnings per share were up 3711 over the past year to 100.

Last 050721 EDT. RT Quote Last NASDAQ LS VOL From CTA USD. Barrons also provides information on historical stock ratings target prices company earnings market.

GBT Stock Price Today Quote News Seeking Alpha.

Global Blood Therapeutics Inc Nasdaq Gbt Analysts Are Cutting Their Estimates Here S What You Need To Know

Eyeing These Global Therapeutics Stock Nasdaq Gbt Price Developments

Global Blood Therapeutics Stock Nasdaq Gbt Breaks Out Here Are The Implications

Global Blood Therapeutics Share Price Gbt Stock Quote Charts Trade History Share Chat Financials Global Blood Therapeutics Inc

Global Blood Therapeutics Stock Declines After Forsaking Half Its Drug Pipeline Marketwatch

Gbt Stock Must Maintain Current Level Of Price Support

Global Blood Therapeutics Oxbryta Is Aimed For Success Nasdaq Gbt Seeking Alpha

Eyeing These Global Therapeutics Stock Nasdaq Gbt Price Developments

Gbt Global Blood Therapeutics Stock Price

Rbc These 3 Stocks Are Poised To Surge By At Least 30 Nasdaq

Gbt Institutional Ownership Global Blood Therapeutics Inc

Loss Making Global Blood Therapeutics Inc Nasdaq Gbt Expected To Breakeven In The Medium Term

Global Blood Therapeutics Stock Sell Off Alters My Investment Strategy Gbt Seeking Alpha

Global Blood Therapeutics Investment Risk Diminishing As Oxbryta Outperforms Nasdaq Gbt Seeking Alpha

Global Blood Therapeutics Can This Biotech Still Disrupt The Sickle Cell Disease Space

Global Blood Therapeutics Share Price Gbt Stock Quote Charts Trade History Share Chat Financials Global Blood Therapeutics Inc

Technical Analysis Global Blood Therapeutics Stock Nasdaq Gbt Chart Is A Must See

Is Global Blood Therapeutics Nasdaq Gbt A Risky Investment

Global Blood Therapeutics Share Price Gbt Stock Quote Charts Trade History Share Chat Financials Global Blood Therapeutics Inc